Skip to main content
Top
Published in: Applied Health Economics and Health Policy 4/2020

01-08-2020 | COVID-19 | Original Research Article

The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis

Authors: Vincenzo Alfano, Salvatore Ercolano

Published in: Applied Health Economics and Health Policy | Issue 4/2020

Login to get access

Abstract

Background

There has been much debate about the effectiveness of lockdown measures in containing COVID-19, and their appropriateness given the economic and social cost they entail. To the best of our knowledge, no existing contribution to the literature has attempted to gauge the effectiveness of lockdown measures over time in a longitudinal cross-country perspective.

Objectives

This paper aims to fill the gap in the literature by assessing, at an international level, the effect of lockdown measures (or the lack of such measures) on the numbers of new infections. Given this policy’s expected change in effectiveness over time, we also measure the effect of having a lockdown implemented over a given number of days (from 7 to 20 days).

Methods

We pursue our objectives by means of a quantitative panel analysis, building a longitudinal dataset with observations from countries all over the world, and estimating the impact of lockdown via feasible generalized least squares fixed effect, random effects, generalized estimating equation, and hierarchical linear models.

Results

Our results show that lockdown is effective in reducing the number of new cases in the countries that implement it, compared with those countries that do not. This is especially true around 10 days after the implementation of the policy. Its efficacy continues to grow up to 20 days after implementation.

Conclusion

Results suggest that lockdown is effective in reducing the R0, i.e. the number of people infected by each infected person, and that, unlike what has been suggested in previous analyses, its efficacy continues to hold 20 days after the introduction of the policy.
Appendix
Available only for authorised users
Literature
2.
go back to reference Piguillem F, Shi L. The optimal covid-19 quarantine and testing policies (No. 2004). Einaudi Institute for Economics and Finance (EIEF). 2020 Piguillem F, Shi L. The optimal covid-19 quarantine and testing policies (No. 2004). Einaudi Institute for Economics and Finance (EIEF). 2020
3.
go back to reference Figueiredo AM, Daponte Codina A, Figueiredo M, Saez M, Cabrera León A. Impact of lockdown on COVID-19 incidence and mortality in China: an interrupted time series study. Bull World Health Organ. Figueiredo AM, Daponte Codina A, Figueiredo M, Saez M, Cabrera León A. Impact of lockdown on COVID-19 incidence and mortality in China: an interrupted time series study. Bull World Health Organ.
4.
go back to reference Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, et al. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020;27(3):37.CrossRef Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, et al. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020;27(3):37.CrossRef
8.
go back to reference Cruz BS, de Oliveira Dias M. COVID-19: from outbreak to pandemic. Global Sci J. 2020;8(3). Cruz BS, de Oliveira Dias M. COVID-19: from outbreak to pandemic. Global Sci J. 2020;8(3).
9.
go back to reference Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.CrossRef Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.CrossRef
10.
go back to reference Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith H, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–82.CrossRef Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith H, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–82.CrossRef
11.
go back to reference Aigner DJ, Balestra M. Optimal experimental design for error components models. Econometrica. 1988;56(4):955–71.CrossRef Aigner DJ, Balestra M. Optimal experimental design for error components models. Econometrica. 1988;56(4):955–71.CrossRef
12.
go back to reference Hsiao C. Analysis of panel data. Cambridge: Cambridge University Press; 1986. Hsiao C. Analysis of panel data. Cambridge: Cambridge University Press; 1986.
13.
go back to reference Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13–22.CrossRef Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13–22.CrossRef
14.
go back to reference Zeger S, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrika. 1986;42(1):121–30.CrossRef Zeger S, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrika. 1986;42(1):121–30.CrossRef
15.
go back to reference Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods. Sage; 1992. Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods. Sage; 1992.
Metadata
Title
The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis
Authors
Vincenzo Alfano
Salvatore Ercolano
Publication date
01-08-2020
Publisher
Springer International Publishing
Keyword
COVID-19
Published in
Applied Health Economics and Health Policy / Issue 4/2020
Print ISSN: 1175-5652
Electronic ISSN: 1179-1896
DOI
https://doi.org/10.1007/s40258-020-00596-3

Other articles of this Issue 4/2020

Applied Health Economics and Health Policy 4/2020 Go to the issue